Cart

0

Stocks

“These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital”

“Cellectar Biosciences (CLRB)… Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price… Continue Reading…

Stocks

“These 3 Penny Stocks Could Rally Over 100%, Says Roth Capital”

“CohBar (CWBR)… Overall, CWBR has a small, but vocal camp of bullish analysts with positive expectations for its stock. Out of the 2 analysts polled by TipRanks, both rate the stock a Buy. With a return potential of 557%, the… Continue Reading…

Stocks

“These 2 Penny Stocks Are Poised for a Massive Rally, Says Roth Capital”

“Seelos Therapeutics (SEEL)… Turning now to the rest of the Street, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, SEEL has a Moderate Buy consensus rating. With the average price target clocking… Continue Reading…